NEWS
Our Latest News
ARCHIMED completes seventh acquisition for NAMSA, the world leader in Medical Device testing services
ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products
October
5,
2021
ARCHIMED’s NAMSA consolidates leadership in Medical Device Clinical Research, buying Clinlogix
August
2,
2021
ARCHIMED buys Stragen Pharma, a leader in the development, registration and distribution of hard-to-make generic drugs
June
24,
2021
ARCHIMED’s Fytexia buys B Natural, the European leader in the extraction and refinement of compounds produced by bees
June
1,
2021
ARCHIMED’s Direct Healthcare Group buys United Care BV
March
24,
2021
368